1-3 of 3
Dorothea Gadzicki
Close
Sort by
Journal Articles

In CML, Marrow Fibrosis Relapses or Emerges in 5 - 6 % of Patients Per Year Independently Indicating Imatinib Failure and Shortened Survival Time of Patients.

Guntram Buesche, Rudiger Hehlmann, Arnold Ganser, Hartmut Hecker, Andreas Hochhaus, Hermann Heimpel, Barbara Heinze, Claudia Schoch, PD., Dorothea Gadzicki, Martin Mueller, Nils von Neuhoff, Susanne Schnittger, PD., Brigitte Schlegelberger, Bernd Frye, Axel Georgii, Hans Kreipe
Journal: Blood
Blood (2006) 108 (11): 2195.
https://doi.org/10.1182/blood.V108.11.2195.2195
Published: 2006
Journal Articles

Emerging Marrow Fibrosis Is an Early Indicator of Imatinib Failure and Shortened Survival Time in CML Independent of Hematologic, Cytogenetic and Molecular Response.

Guntram Buesche, Ruediger Hehlmann, Arnold Ganser, Hartmut Hecker, Mathias Freund, Hermann Heimpel, Barbara Heinze, Dorothea Gadzicki, Brigitte Schlegelberger, Christa Fonatsch, Bernd Frye, Andreas Tobler, Axel Georgii, Hans H. Kreipe
Journal: Blood
Blood (2005) 106 (11): 1106.
https://doi.org/10.1182/blood.V106.11.1106.1106
Published: 2005
Journal Articles

Fluorescence In Situ Hybridization (FISH) Using a Subtelomeric 11q Probe as a New Diagnostic Tool for Congenital Thrombocytopenia Caused by Deletions in 11q.

Dorothea Gadzicki, MD, Gudrun Michaelsen, MD, Cornelia Rudolph, Doris Steinemann, PhD, Christoph M. Happel, MD, Karl Welte, MD, PhD, Christoph Klein, MD, PhD, Holger Toennies, PhD, Peter Lichter, PhD, Udo Kontny, MD, Charlotte Marie Niemeyer, MD, PhD, Brigitte Schlegelberger, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 3035.
https://doi.org/10.1182/blood.V104.11.3035.3035
Published: 2004